GPRC5D and FCRH5 Targeted Therapies in Myeloma Published 2023-06-16 Download video MP4 360p Download video MP4 720p Recommendations 1:00:53 How Fast Can Multiple Myeloma Progress and What Biologically Happens When It Does? 1:15:00 Smoldering Myeloma: What We Know and Where We're Going 1:03:18 Emerging Research in the Smoldering Myeloma Field with Dr. Kazandjian 59:07 Is There a Need for Tandem Transplants in Today's Myeloma? 17:18 Low Sodium and How to Prevent Osmotic Demyelination Syndrome 27:39 Using CAR-T Therapy Strategically in Myeloma Care | Charlotte Roundtable, May 4th, 2024 1:16:24 Know Your Myeloma Therapy: REVLIMID with Dr. Craig Cole 53:06 How to Optimize Your Health as a Myeloma Patient 09:25 The 'Messy' Data on Chromosome 1 Abnormalities and Multiple Myeloma Treatment - Medpage Today 18:40 Matthew Perry's Death From Ketamine Explained (Is It Safe For You?) 1:03:18 Making Rounds: Medical Education Documentary Film 57:50 ImmunoPET- an Advanced Companion to MRD Testing 04:37 What is CAR T Cell Therapy? 10:37 Top 4 Inherited Mental Health Disorders: What You Need to Know 1:06:37 CCF Webinar: Precision Medicine in Cholangiocarcinoma 11:41 Multiple Myeloma - signs and symptoms, pathophysiology, treatment 59:54 Will the Smoldering Myeloma Diagnosis Phase Out? 31:15 Precision Medicine in Myeloma | Miami RoundTable April 20, 2024 51:48 Webinar: Novel treatment approaches for intrahepatic cholangiocarcinoma 03:15 What is the best diet for myeloma patients to build a strong immune system? Similar videos 02:14 Going beyond BCMA-targeting agents in myeloma: GPRC5D and FcRH5-targeting therapies 05:21 Beyond BCMA: GPRC5D & FcRH5 00:41 FcRH5 & GPRC5D bispecific antibodies: antigen targets beyond BCMA for multiple myeloma 01:10 The importance of BCMA, FcRH5 and GPRC5D in multiple myeloma 01:47 A New Target for CAR-T Therapy in Myeloma - GPRC5D | Fredrik Schjesvold, MD | ASH 2021 01:24 Bispecifics & CARs: BCMA, GPRC5D & FcRH5 sequencing 00:42 How Can GPRC5D and FCRH5 Therapies Benefit My Myeloma Treatment? 01:48 Mechanisms behind the loss of BCMA in multiple myeloma & options for patients 00:48 Myeloma: the groovy new GPRC5D 58:19 Sequencing BCMA Myeloma Therapies 05:59 Using Different Targets to Destroy Multiple Myeloma 06:45 Phase I trial of a FcRH5-targeted BiTE in R/R myeloma 04:15 Talquetamab: GPRC5D-CD3 bispecific antibody in R/R myeloma 03:44 What should myeloma patients know about talquetamab? 02:48 Novel targets in multiple myeloma 01:16 Latest advances in immunotherapy for multiple myeloma: targets, alloCAR-Ts & immunomodulatory drugs 02:00 Treating multiple myeloma resistant to BCMA-targeted therapy 02:53 Novel targets and dual-targeting approaches in myeloma 05:32 Myeloma Made Simple: Bispecific Antibody Targets Made Simple | Myeloma Targeting with Bispecifics More results